SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000849146-20-000116
Filing Date
2020-08-18
Accepted
2020-08-18 16:08:24
Documents
16
Period of Report
2020-08-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lfvn-20200818.htm   iXBRL 8-K 45245
2 EX-99.1 lfvnq42020earningsrele.htm EX-99.1 373534
8 logoa231.jpg GRAPHIC 6462
  Complete submission text file 0000849146-20-000116.txt   596975

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20200818.xsd EX-101.SCH 2445
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20200818_cal.xml EX-101.CAL 728
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20200818_def.xml EX-101.DEF 1665
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20200818_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20200818_pre.xml EX-101.PRE 13208
9 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20200818_htm.xml XML 12083
Mailing Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070
Business Address 9785 S. MONROE STREET SUITE 300 SANDY UT 84070 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 841097796 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35647 | Film No.: 201113703
SIC: 2834 Pharmaceutical Preparations